BRILLIANT I
BRILLIANT I
A trial designed to demonstrate the safety of the Batimastat BiodivYsio stent, in a 150-patient cohort that underwent angiography at 6 months. Review of the data from BRILLIANT I did not show the benefit that was evident in the pre-clinical studies, which led to suspension of patient recruitment for BRILLIANT II.Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
Copyright © 2003-2025 Farlex, Inc
Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.